UnknownPhase 2NCT03469531
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Studying Squamous cell carcinoma of the cervix uteri
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Zhujiang Hospital
- Principal Investigator
- junguo bu, doctorZhujiang Hospital
- Intervention
- Nimotuzumab(drug)
- Enrollment
- 100 target
- Eligibility
- 18-75 years · FEMALE
- Timeline
- 2018 – 2021
Study locations (1)
- Zhujiang Hospital, Guangzhou, Guangdong, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03469531 on ClinicalTrials.gov